Best OTC

Reported by: Emon CRWE Newswire Middle East correspondent

In New York City once again police discovered a suspicious vehicle, a Mercedes. Just what made this Mercedes suspicious was that it had been parked in the same place for several hours.

Thursday over local television station Fox New York, someone called and advised that a suspicious vehicle had been parked in the same location for several hours, the police around 6:00a.m called out the bomb squad.

A few minutes later the police closed off several blocks of the city, located between 50th and 57th Streets, adjacent to Park Avenue.

According to law enforcement, a suspicious car was parked near the intersection of 51th Street and Park Avenue, located in the eastern part of Manhattan.

After evaluating the incident New York City police said nothing suspicious was found in a Mercedes parked for several hours in midtown Manhattan it had however been fully inspected as a precaution.

The scene was cleared, pedestrian and street traffic that had been briefly blocked while the bomb squad investigated the car were later allowed through.

********************************************************************

The Views and Opinions Expressed by the author are his or her opinions only and do not necessarily reflect those of this Web-Site or its agents, affiliates, officers, directors, staff, or contractors. The author at the time of this article did not own any shares or receive any consideration financial or otherwise from any company or person mentioned or referred to in the article.

PROTEONOMIX, INC. (OTC.BB:PROT), a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, reported that Mr. Michael Cohen, Chairman and CEO, is scheduling a multi-city European road trip to create additional awareness of the Proteonomix, Inc. investment opportunity to institutional investors.

Scheduled for early October, Mr. Cohen will discuss with sophisticated investors the recent contract to establish a joint venture with a group of investors that will establish a new stem cell treatment and research facility in the United Arab Emirates (U.A.E.). In addition, Mr. Cohen will discuss the opportunity to set up additional joint ventures in other countries using the U.A.E. arrangement as a model.

The recent contract calls for the joint venture partner to invest $5 million on or before September 10, 2010 in a Joint Venture company, XGEN Medical LLC. (”XGen”), a Nevis Island limited liability company. For additional details about the joint venture agreement, please refer to the August 17, 2010 press release.

“Proteonomix has made great strides recently,” stated Mr. Cohen, “and we have been contacted by several European entities that have requested additional information about our proprietary stem cell activities. In recognition of the interest in Europe and the potential for additional joint venture agreements in various European countries, we recognize that it is propitious to meet with a number of the European institutional investors both to educate them on the intrinsic value of Proteonomix shares and garner interest in strategic relationships.”

Proteonomix is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. Proteoderm, Inc. is a wholly owned subsidiary of Proteonomix that has recently opened its retail web site, Proteoderm.com, and begun accepting pre-orders for its anti-aging line of skin care products. StromaCel, Inc.’s goal is the development therapeutic modalities for the treatment of Cardiovascular Disease (CVD). StromaCel, Inc. is pursuing the licensing of other technologies for therapeutic use. National Stem Cell, Inc. is Proteonomix’s operating subsidiary. The Sperm Bank of New York, Inc. is a fully operational tissue bank. Proteonomix Regenerative Translational Medicine Institute, Inc. (”PRTMI”) intends to focus on the translation of promising research in stem cell biology and cellular therapy to clinical applications of regenerative medicine. Proteonomix intends to create and dedicate a subsidiary to each of its technologies.

MusclePharm Corporation (OTCBB:MSLP), one of the fastest growing nutritional supplement companies in the United States with a proprietary formulation used in eight performance products, reports that MuscleGel achieves NSF certification. In addition, the Company’s Recon and Assault nutritional products will be NSF certified within the coming months.

NSF International is an independent, not-for-profit organization that meets the growing demands of athletes, coaches and all those concerned about banned substances in sports supplements. NSF International created the new NSF Certified for Sport Program. This new NSF program is a focused solution designed to minimize the risk that a dietary supplement or sports nutrition product contains banned substances. This program is part of NSF’s successful 60-year history of providing certification programs for food, water and consumer goods.

MLB, the MLB Player’s Association, NFL, the NFL Player’s Association, PGA, LPGA and the CCES have all chosen NSF’s Certified for Sport program to help verify the products their athletes use are safer and free of banned substances. NSF GMP for Sport certification verifies that the facility, operations and ingredient sourcing are in compliance with GMP requirements via ongoing audits.

MusclePharm products are currently available in 1,200 of the top General Nutrition Centers (GNC) in the United States, as well as Vitamin Shop. MusclePharm’s award-winning products — Assault, Battle Fuel, Bullet Proof, Combat Powder, Recon and Shred Matrix—are also available online at gnc.com, bodybuilding.com, amazon.com and many other locations.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. BestOtc.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer ( http://bestotc.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold BestOTC.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

Crown Equity Holdings Inc. (CRWE.OB) has received twenty five thousand dollars in cash and seventy five thousand free trading shares from a third party (Bishop Equity Partners) for (30) days of advertising for Muscle Pharm Corp. (MSLP.OB).

Crown Equity Holdings Inc. (CRWE.OB) has received twenty thousand dollars in cash and twenty thousand dollars in free trading shares from a third party (Swiss Financial Report) for (30) days of advertisement services for Proteonomix, Inc. (PROT.OB)

Reported by: Emon CRWE Newswire Middle East correspondent.

President Barack Obama signed an executive order extending sanction against North Korea. Hoping to bring N. Korea in line with the rest of the world, but these sanctions are expected by major think tanks to have kittle results.

U.S Finance Ministry in this regard has distributed an additional list of organizations and individuals of DPRK, whose assets will be frozen in connection with their involvement in the missile and nuclear programs.

On this lists, U.S will freeze four North Korean individuals, three companies and five government agencies. Will Brown and Root, Bechtel, and Halliburton be among those listed?

The intention to impose new sanctions against North Korea was announced last month in South Korea, by Secretary of State Hillary Clinton. She said the restrictions are aimed at “selling and buying of arms and related materials, luxury goods, as well as other illegal activities.” And also include the freezing of bank accounts of individuals.
The North Korean regime has been under pressure because of tightened sanctions, shriveling trade amid increased international isolation, food shortages and a poor currency reform last year.

But the issue remains will these sanctions really make a difference or will North Korea become more antagonistic towards the west and our allies. in short, what will work to bring N. Korea into the fold, the carrot, or the stick?

********************************************************************

The Views and Opinions Expressed by the author are his or her opinions only and do not necessarily reflect those of this Web-Site or its agents, affiliates, officers, directors, staff, or contractors. The author at the time of this article did not own any shares or receive any consideration financial or otherwise from any company or person mentioned or referred to in the article.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWENewswire.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWENewswire.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more) Rule 17B requires disclosure of payment for investor relations.

Reported by: Emon CRWE Newswire Middle East correspondent.

Scientists have deciphered the genome of wheat, ta revolution in agriculture is coming.

British scientists were finally able to decipher the genome of wheat, which is one of the world’s oldest and most staple and important crops.

Because of this discovery, the researchers said in the coming years we will be capable of bringing disease-resistant wheat varieties to market.

By this development scientists hope to help the global staple to meet the challenges of climate change, disease and population growth.

A member of the research team Anthony Hall said that “the procurement of wheat is under great pressure, especially by the failure of production in Russia, which greatly increases prices. It is expected that in the next 40 years food production will have to increase by 50% and development of wheat varieties that require low input and provide a high performance is essential to manage the increased demand”.

As a consequence, we will speak about reducing the price of bread and improve food security worldwide. The results of the study can look to any producer of wheat.

********************************************************************

The Views and Opinions Expressed by the author are his or her opinions only and do not necessarily reflect those of this Web-Site or its agents, affiliates, officers, directors, staff, or contractors. The author at the time of this article did not own any shares or receive any consideration financial or otherwise from any company or person mentioned or referred to in the article.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWENewswire.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWENewswire.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more) Rule 17B requires disclosure of payment for investor relations.

Reported by: Eric CRWE Newswire Middle East correspondent

The Euro advanced to 1.2900 against the greenback while the British Pound remained flat at 1.5447 against the US dollar.

The US dollar declined to 84.15 against the Japanese Yen hovering near its 15 year low but the better US jobs data for the month of August kept the greenback from reaching that level.

The dollar index DXY which is a measurement of the US dollar movement against its major counterpart currencies declined 0.1 percent to 82.02.

The Stock market globally maintained bullish sentiments on the news that US private sector has added 67,000 jobs for the month of August. And discounted the 54,000 job losses.

In London, FTSE 100 index advanced 0.3% to 5,445.05, Germany’s DAX surged 0.24% to 6,149.30 while CAC-40 advanced 0.25% to 3681.38 points.

In Asia, Japan’s Nikkei 225 stock index advanced 2.1% to close at 9,301.32, Hang Seng index surged 1.8 percent to 21,355.77 while Korea’s Kospi also advanced 0.7 percent to close at 1,792.42 points for the day.

The Shanghai Composite index gained 1.54% to close at 2,696.25 while Singapore’s Strait Times index advanced 1.07% to close at 3,034.58 for the day.

Crude oil prices remained under $74 on concern of rising oil demand from China which could affect fuel consumption in the United States already facing high unemployment.

Crude oil future contracts for October delivery declined $0.22 to $74.38 per barrel in New York Mercantile Exchange in Singapore’s trading session while Brent crude dropped $0.06 to $76.61 on the ICE Futures exchange at London.

********************************************************************

The Views and Opinions Expressed by the author are his or her opinions only and do not necessarily reflect those of this Web-Site or its agents, affiliates, officers, directors, staff, or contractors. The author at the time of this article did not own any shares or receive any consideration financial or otherwise from any company or person mentioned or referred to in the article.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWENewswire.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWENewswire.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more) Rule 17B requires disclosure of payment for investor relations.